Morning Briefing
Summaries of health policy coverage from major news organizations
Sanofi-Aventis, Medtronic Under Scrutiny In Press Reports
ProPublica details alleged activities by Sanofi-Aventis to influence regulators regarding its brand-name blood thinner, Lovenox, while other news outlets report on Medtronic's activities related to a biological agent used in back surgery.
This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
